
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
G530011O06Rik CRISPR/Cas9 KO Plasmid (m) | sc-437289 | 20 µg | $397.00 |
Mouse G530011O06Rik encodes a largely uncharacterized protein with limited functional annotation, making it a useful target for discovery-oriented studies of gene regulation and cellular homeostasis. Available evidence from genomic context and expression profiling suggests potential roles in fundamental processes such as transcriptional control, RNA metabolism, or intracellular signaling, depending on cell type and developmental stage. Because many RIKEN cDNA genes map to conserved mammalian loci, perturbation of G530011O06Rik can help clarify how poorly annotated proteins contribute to pathway architecture and phenotype. Systematic loss-of-function interrogation may be informative for identifying links to stress responses, differentiation programs, or disease-relevant molecular signatures in mouse model systems.
G530011O06Rik CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the G530011O06Rik gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the G530011O06Rik together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the G530011O06Rik open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish G530011O06Rik protein expression.
This CRISPR knockout system enables efficient generation of G530011O06Rik-deficient cell models for investigation of G530011O06Rik signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.